Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Asthma D001249 52 associated lipids
Nerve Degeneration D009410 53 associated lipids
Parkinson Disease D010300 53 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Weight Loss D015431 56 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Pain D010146 64 associated lipids
Reperfusion Injury D015427 65 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Neuroblastoma D009447 66 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Colitis D003092 69 associated lipids
Melanoma D008545 69 associated lipids
Coronary Disease D003327 70 associated lipids
Leukemia D007938 74 associated lipids
Stomach Ulcer D013276 75 associated lipids
Alzheimer Disease D000544 76 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Atherosclerosis D050197 85 associated lipids
Arteriosclerosis D001161 86 associated lipids
Seizures D012640 87 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Brain Ischemia D002545 89 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Weight Gain D015430 101 associated lipids
Glioma D005910 112 associated lipids
Hypertension D006973 115 associated lipids
Inflammation D007249 119 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Hemolysis D006461 131 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Edema D004487 152 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Adenocarcinoma D000230 166 associated lipids
Lung Neoplasms D008175 171 associated lipids
Body Weight D001835 333 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Paubert-Braquet M et al. Platelet-activating factor amplifies tumour necrosis factor-induced superoxide generation by human neutrophils. 1990 Adv. Exp. Med. Biol. pmid:2173875
Vernadakis A et al. C-6 glioma cells of early passage have progenitor properties in culture. 1991 Adv. Exp. Med. Biol. pmid:1685850
Yue TL et al. Platelet-activating factor (PAF)--a putative mediator in inflammatory tissue injury. 1991 Adv. Exp. Med. Biol. pmid:1667965
Schlondorff D Interactions of platelet activating factor and prostaglandins in the glomerulus and in mesangial cells. 1989 Adv. Exp. Med. Biol. pmid:2696352
Remuzzi G Eicosanoids and platelet activating factor as possible mediators of injury in experimental nephropathies. 1989 Adv. Exp. Med. Biol. pmid:2696353
Vadas P and Pruzanski W Phospholipase A2 activation is the pivotal step in the effector pathway of inflammation. 1990 Adv. Exp. Med. Biol. pmid:2239447
Kornecki E et al. Interactions of the alkyl-ether-phospholipid, platelet activating factor (PAF) with platelets, neural cells, and the psychotropic drugs triazolobenzodiazepines. 1987 Adv. Exp. Med. Biol. pmid:2893525
MacIntyre DE et al. Agonist-induced inositol phospholipid metabolism and Ca++ flux in human platelet activation. 1985 Adv. Exp. Med. Biol. pmid:3010662
Hallam TJ et al. Control and interrelation of aggregation and secretion; the roles of Ca2+, diacylglycerol and thromboxane with particular reference to ADP stimulation. 1985 Adv. Exp. Med. Biol. pmid:3010663
Gerrard JM et al. Platelet protein phosphorylation. 1985 Adv. Exp. Med. Biol. pmid:3010667
Haslam RJ et al. Receptor-effector coupling in platelets: roles of guanine nucleotides. 1985 Adv. Exp. Med. Biol. pmid:3010668
Maes L et al. In vivo arterial platelet-vessel wall interaction and thrombosis: induction, on-line registration and ultrastructural control. 1985 Adv. Exp. Med. Biol. pmid:3832867
Tuffin DP et al. Specific binding of [3H]-1-O-octadecyl Paf-acether to washed human platelets. 1985 Adv. Exp. Med. Biol. pmid:3834789
Bourgain RH et al. Arterial obstruction induced by PAF-acether (1-O-alkyl-sn-glycero-3-phosphocholine). 1987 Adv. Exp. Med. Biol. pmid:3673721
Fisher RA et al. AGEPC: a potent calcium-dependent chemical mediator in the liver. 1988 Adv. Exp. Med. Biol. pmid:3213685
Bourgain RH et al. PAF-acether induced arterial thrombosis and the effect of specific antagonists. 1992 Adv. Exp. Med. Biol. pmid:1288104
van Rossem K et al. The role of PAF and the effect of a specific PAF antagonist on local tissue PO2 and neuronal integrity during and after photothrombotic brain infarction in unanesthetised rabbits. 1996 Adv. Exp. Med. Biol. pmid:8798843
Camussi G et al. The release of platelet-activating factor during phagocytosis by polymorphonuclear neutrophils and monocytes. 1982 Adv. Exp. Med. Biol. pmid:7090917
Shimizu T and Mutoh H Structure and regulation of platelet activating factor receptor gene. 1997 Adv. Exp. Med. Biol. pmid:9321953
Mori M et al. Localization of platelet-activating factor receptor in the rat brain. 1997 Adv. Exp. Med. Biol. pmid:9321976
Erickson KL et al. Alteration of platelet activating factor-induced macrophage tumoricidal response, IA expression, and signal transduction by N-3 fatty acids. 1997 Adv. Exp. Med. Biol. pmid:9321978
Muguruma K et al. The central role of PAF in necrotizing enterocolitis development. 1997 Adv. Exp. Med. Biol. pmid:9321979
Aoki Y et al. A simple, rapid and specific radioreceptor assay for platelet-activating factor. 1997 Adv. Exp. Med. Biol. pmid:9321990
Si Y et al. The change in plasma PAF activity before and after delivery. 1997 Adv. Exp. Med. Biol. pmid:9322006
Hanahan DJ The continuing biochemical challenge of PAF and closely related lipid mediators. 1996 Adv. Exp. Med. Biol. pmid:9131117
Snyder F et al. Biosynthesis of platelet-activating factor and enzyme inhibitors. 1996 Adv. Exp. Med. Biol. pmid:9131118
Satoh K et al. Production of platelet-activating factor by brain microvascular endothelial cells. 1996 Adv. Exp. Med. Biol. pmid:9131120
Francescangeli E et al. PAF-synthesizing enzymes in neural cells during differentiation and in gerbil brain during ischemia. 1996 Adv. Exp. Med. Biol. pmid:9131121
Yamada M et al. Platelet-activating factor production in the stimulated macrophages is enhanced by the cyclooxygenase inhibitors. 1996 Adv. Exp. Med. Biol. pmid:9131122
Ye RD et al. Stimulation of NF-kappa B activation and gene expression by platelet-activating factor. 1996 Adv. Exp. Med. Biol. pmid:9131140
Shukla SD Tyrosine kinase activation by PAF leads to downstream gene expression. 1996 Adv. Exp. Med. Biol. pmid:9131141
Morooka S and Natsume Y Effect of SM-12502 on disseminated intravascular coagulation (DIC) in tumor-bearing rats. 1996 Adv. Exp. Med. Biol. pmid:9131147
Sanchez Crespo M et al. Platelet-activating factor is an effector of rapid reactions and an inductor of late responses in immune-mediated injury. 1996 Adv. Exp. Med. Biol. pmid:9131148
Saito K PAF response to inflammatory and non-inflammatory stimuli. 1996 Adv. Exp. Med. Biol. pmid:9131150
Silver D et al. Role of platelet-activating factor in skeletal muscle ischemia-reperfusion injury. 1996 Adv. Exp. Med. Biol. pmid:9131151
Lopes-Martins RA et al. Platelet-activating factor. A possible role in the modulation of the vasomotor tone and blood pressure. 1996 Adv. Exp. Med. Biol. pmid:9131152
Camussi G et al. Platelet-activating factor and angiogenesis. 1996 Adv. Exp. Med. Biol. pmid:9131153
Oh-Ishi S et al. Role of synergistic action of PAF and kinin in bacterial endotoxin-induced hypotension in rats. 1996 Adv. Exp. Med. Biol. pmid:9131154
Tetta C et al. The role of platelet-activating factor in the biocompatibility of hemodialysis membranes. 1996 Adv. Exp. Med. Biol. pmid:9131156
O'Neill C PAF promotes the development of the preimplantation embryo. 1996 Adv. Exp. Med. Biol. pmid:9131158
Ammit AJ and O'Neill C PAF released by preimplantation embryos binds to albumin. 1996 Adv. Exp. Med. Biol. pmid:9131159
Narahara H et al. Role of platelet-activating factor in parturition. 1996 Adv. Exp. Med. Biol. pmid:9131160
Ahmed A and Dearn S The role of platelet-activating factor and its receptor in endometrial receptivity. 1996 Adv. Exp. Med. Biol. pmid:9131161
Korth RM Non-specific PAF binding to embryonal F9 cells and prostacyclin synthesis in human umbilical vein endothelial cells. 1996 Adv. Exp. Med. Biol. pmid:9131162
Zimmerman GA et al. Platelet-activating factor (PAF): signalling and adhesion in cell-cell interactions. 1996 Adv. Exp. Med. Biol. pmid:9131163
Yang HC et al. Characterization of plasmalogen-selective phospholipase A2 from bovine brain. 1996 Adv. Exp. Med. Biol. pmid:9131165
Ferby I et al. PAF-induced MAPK activation is inhibited by wortmannin in neutrophils and macrophages. 1996 Adv. Exp. Med. Biol. pmid:9131167
Thierse HJ et al. Evidence for activation of cyclooxygenase-1/-2 by endogenous nitric oxide in adjuvant arthritic Lewis rats. 1996 Adv. Exp. Med. Biol. pmid:9131171
Curtis LD Lexipafant (BB-882), a potent PAF antagonist in acute pancreatitis. 1996 Adv. Exp. Med. Biol. pmid:9131174
Elizarova EP Effects of taurine on calcium in platelets and their aggregation. 1996 Adv. Exp. Med. Biol. pmid:8915398
Ohkuni H et al. Purification and partial characterization of a novel human platelet aggregation factor in the extracellular products of Streptococcus mitis, strain Nm-65. 1997 Adv. Exp. Med. Biol. pmid:9331745
Kosar-Hashemi B et al. Glyceryl ether monooxygenase [EC 1.14.16.5]: stoichiometry and inhibition. 1993 Adv. Exp. Med. Biol. pmid:8304231
Pirotzky E et al. Involvement of platelet-activating factor in renal processes. 1989 Adv. Lipid Res. pmid:2698054
Holleran WM Lipid modulators of epidermal proliferation and differentiation. 1991 Adv. Lipid Res. pmid:1763711
Koltai M et al. Platelet-activating factor antagonists: scientific background and possible clinical applications. 1994 Adv. Pharmacol. pmid:8080821
Summers JB and Albert DH Platelet activating factor antagonists. 1995 Adv. Pharmacol. pmid:7748804
Sullivan MH et al. Altered platelet responses to P.A.F. in pregnancy-induced hypertension. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825415
Braquet P et al. From ginkgolides to N-substituted piperidino-thieno diazepines, a new series of highly potent dual antagonists. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825436
Berti F et al. Opposite effects of PGI2 and PAF generated during acute myocardial ischemia in the perfused rabbit heart. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825437
Takatani M et al. Platelet activating factor (PAF) antagonists: development of a highly potent PAF antagonist, TCV-309. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825438
Kawabe T et al. Role of PAF and cytokines in the modulation of Fc epsilon RII/CD23 expression on human eosinophils. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825444
Weber PC and Sellmayer A Modification of the eicosanoid system and cell signalling by precursor fatty acids. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825543
Balazy M et al. A novel method for the analysis of PAF and alkyl-ether phospholipids by mass spectrometry. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825562
Magni F et al. Determination of platelet-activating factor in biological samples by high resolution mass spectrometry. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825563
Coceani F et al. Leukotrienes in cerebrospinal fluid of the conscious cat: effect of platelet-activating factor and pyrogens. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825586
Shen TY et al. Recent development of platelet-activating factor antagonists. 1989 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2546389
Handley DA et al. Chemistry and pharmacology of PAF antagonists. Evaluation of changes at potential metabolism sites on activity and duration of activity. 1989 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2546390
Dray F et al. Recent studies on icosanoids and PAF-acether modulation of some central neurosecretions in the rat. 1989 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2546391
Desquand S et al. Interference of the PAF-acether antagonist BN 52021 with anaphylaxis in the guinea pig. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2445183
Benveniste J PAF-acether (platelet-activating factor). 1989 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2526498
Hsueh W and Sun XM Tumor necrosis factor-induced bowel necrosis: the role of platelet-activating factor. 1989 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2526499
Pignol B et al. Effect of chronic administration of platelet-activating factor (PAF) in the guinea-pig and the rat. 1989 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2526500
Foegh ML et al. Platelet-activating factor in organ transplant rejection. 1989 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2526501
Pickett WC and Ramesha C Modulation of mediator precursors by changes in essential fatty acid composition. 1989 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2526546
Bussolino F et al. Chick retina generates platelet-activating factor. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2890284
Braquet P Proofs of involvement of PAF-acether in various immune disorders using BN 52021 (ginkgolide B): a powerful PAF-acether antagonist isolated from Ginkgo biloba L. 1986 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2949548
Foegh ML et al. Leukotrienes, thromboxane, and platelet activating factor in organ transplantation. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2959038
Robertson DN and Smith GM Role of thromboxane A2, 5-hydroxytryptamine, and platelet activating factor in collagen-induced sudden death in rabbits. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2959049
d'Humieres S et al. Platelet activating factor acether is involved in thrombin-induced synthesis of prostacyclin by human endothelial cells. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2959051
Whittle BJ et al. Gastric vascular and mucosal damaging actions of platelet activating factor in the canine stomach. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2959063
Montrucchio G et al. In vitro oxytocic activity of platelet-activating factor on human myometrium. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2960158
Mallet AI et al. Platelet activating factor in chronic plaque psoriasis. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2960170
Bourgain RH et al. Effect of ginkgolide PAF-acether antagonists on arterial thrombosis. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2960196
Braquet P et al. Platelet-activating factor: a potential mediator of shock. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2960197
Myers A et al. Pharmacological manipulation of platelet-activating factor toxicity in rodents. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2960198
Benveniste J Biosynthesis and function of PAF-acether (platelet-activating factor). 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2936197
Waku K et al. Metabolism of 1-O-alkyl-2-acyl-sn-glycero-3-phosphocholine: a precursor of platelet-activating factor in macrophages. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2936199
Saito K et al. Determination of AGEPC generated from human neutrophils and rat skin and muscle tissues by a selected ion monitoring technique of GC/MS. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2936200
Hanahan DJ et al. Platelet-activating factor: a unique lipid chemical mediator. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2936201
Inoue K et al. Activation of guinea pig peritoneal macrophages by platelet-activating factor in free form or incorporated into liposomes. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2936203
Benveniste J Paf-acether (platelet-activating factor). 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:3159192
Matsumoto M and Miwa M Platelet-activating factor-binding protein in human serum. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:3004155
Terashita Z et al. Beneficial effects of (RS)-2-methoxy-3-(octadecylcarbamoyloxy)propyl 2-(3-thiazolio)ethyl phosphate, a specific PAF antagonist, in endotoxin and anaphylactic shock. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:3004156
Livio M et al. A platelet-activating factor receptor antagonist protects against renal function deterioration in nephrotoxic nephritis. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2823570
Vargaftig BB et al. Synergized activation of human platelets by epinephrine and platelet-activating factor-acether is adenosine diphosphate and thromboxane A2-independent. 1983 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:6221558
Voelkel NF et al. Platelet-activating factor causes pulmonary vasoconstriction and edema via platelet-independent leukotriene formation. 1983 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:6221590
Izumi T et al. Regulation and signal transduction of PAF receptor. 1995 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:7732892
Bennett SA and Birnboim HC Platelet activating factor induces transformation of human fibroblasts. 1995 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:7732893
Summers JB et al. ABT-299, a potent antagonist of platelet activating factor. 1995 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:7732895
Meats JE et al. Identification of phospholipase D (PLD) activity in mouse peritoneal macrophages. 1993 Agents Actions pmid:8273553